Synthesis, characterization and cytotoxicity of copper (II) complex containing a 2H-benzo[e][1,3]oxazin derivative.

[1]  C. Penny,et al.  Copper-imidazo[1,2-a]pyridines differentially modulate pro- and anti-apoptotic protein and gene expression in HL-60 and K562 leukaemic cells to cause apoptotic cell death. , 2021, Biochimica et biophysica acta. Molecular cell research.

[2]  R. Safaralizadeh,et al.  Molecular mechanisms of apoptosis induction in K562 and KG1a leukemia cells by a water-soluble copper(II) thiosemicarbazone complex , 2020, JBIC Journal of Biological Inorganic Chemistry.

[3]  M. Vázquez,et al.  Ditopic binuclear copper(II) complexes for DNA cleavage. , 2020, Journal of inorganic biochemistry.

[4]  A. Neves,et al.  Targeting an Artificial Metal Nuclease to DNA by a Simple Chemical Modification and Its Drastic Effect on Catalysis. , 2019, ACS medicinal chemistry letters.

[5]  M. Kubo,et al.  Oxidative DNA Cleavage, Formation of μ-1,1-Hydroperoxo Species, and Cytotoxicity of Dicopper(II) Complex Supported by a p-Cresol-Derived Amide-Tether Ligand. , 2019, Inorganic chemistry.

[6]  M. Scarpellini,et al.  Chlorido(2,2′-{[2-(1-methyl-1H-imidazol-2-yl-κN 3)imidazolidine-1,3-diyl-κN]bis(methylene)}bis(1-methyl-1H-imidazole-κN 3))copper(II) perchlorate , 2019, Acta crystallographica. Section E, Crystallographic communications.

[7]  Abdulaziz A. Alkhedhairy,et al.  Copper(II) complexes as potential anticancer and Nonsteroidal anti-inflammatory agents: In vitro and in vivo studies , 2019, Scientific Reports.

[8]  B. Iglesias,et al.  Pyridoxal derivatized copper(II) complexes: Evaluation of antioxidant, catecholase, and DNA cleavage activity , 2018 .

[9]  Marijana Jukić,et al.  Antiproliferative and proapoptotic activity of molecular copper(II) complex of N-1-tosylcytosine. , 2017, Journal of Trace Elements in Medicine and Biology.

[10]  J. Mahy,et al.  Imidazolidine Ring Cleavage upon Complexation with First‐Row Transition Metals , 2017 .

[11]  N. Tounsi,et al.  Progress in Copper Complexes as Anticancer Agents , 2017 .

[12]  H. Marques,et al.  Synthesis of copper and zinc 2-(pyridin-2-yl)imidazo[1,2-a]pyridine complexes and their potential anticancer activity. , 2017, European journal of medicinal chemistry.

[13]  J. Resende,et al.  In vitro and in vivo studies of the antineoplastic activity of copper (II) compounds against human leukemia THP-1 and murine melanoma B16-F10 cell lines. , 2016, European journal of medicinal chemistry.

[14]  A. Bortoluzzi,et al.  Dopamine polymerization promoted by a catecholase biomimetic CuII(μ-OH)CuII complex containing a triazine-based ligand. , 2016, Dalton transactions.

[15]  F. Pavan,et al.  Synthesis, cytotoxic and antitubercular activities of copper(II) complexes with heterocyclic bases and 3-hydroxypicolinic acid , 2016 .

[16]  S. Tabassum,et al.  A dinuclear copper(II) complex with piperazine bridge ligand as a potential anticancer agent: DFT computation and biological evaluation , 2016 .

[17]  Cunyuan Zhao,et al.  Mechanistic Insights Into the Factors That Influence the DNA Nuclease Activity of Mononuclear Facial Copper Complexes Containing Hetero-Substituted Cyclens , 2016 .

[18]  A. Bortoluzzi,et al.  Induction of apoptosis in leukemia cell lines by new copper(II) complexes containing naphthyl groups via interaction with death receptors. , 2015, Journal of inorganic biochemistry.

[19]  W. Haase,et al.  Synthesis, characterization, hydrolase and catecholase activity of a dinuclear iron(III) complex: Catalytic promiscuity. , 2015, Journal of inorganic biochemistry.

[20]  N. Jain,et al.  Rational design, synthesis and anti-proliferative evaluation of novel 1,4-benzoxazine-[1,2,3]triazole hybrids. , 2015, European journal of medicinal chemistry.

[21]  G. Sheldrick.  Crystal structure refinement with SHELXL , 2015, Acta crystallographica. Section C, Structural chemistry.

[22]  G. Basso,et al.  A novel copper(I) complex induces ER-stress-mediated apoptosis and sensitizes B-acute lymphoblastic leukemia cells to chemotherapeutic agents , 2014, Oncotarget.

[23]  Chris Orvig,et al.  Metallodrugs in medicinal inorganic chemistry. , 2014, Chemical reviews.

[24]  V. Gandin,et al.  Advances in copper complexes as anticancer agents. , 2014, Chemical reviews.

[25]  Cheree Fitzgibbon,et al.  Chemo-sensitisation of HeLa cells to Etoposide by a Benzoxazine in the absence of DNA-PK inhibition , 2013, Investigational New Drugs.

[26]  Geovana G. Terra,et al.  2,2′-{[2-(Pyridin-2-yl)-1,3-diazinane-1,3-diyl]bis(methylene)}diphenol , 2012, Acta crystallographica. Section E, Structure reports online.

[27]  W. Haase,et al.  Synthesis, magnetostructural correlation, and catalytic promiscuity of unsymmetric dinuclear copper(II) complexes: models for catechol oxidases and hydrolases. , 2012, Inorganic chemistry.

[28]  B. Gyurcsik,et al.  Towards artificial metallonucleases for gene therapy: recent advances and new perspectives. , 2011, Future medicinal chemistry.

[29]  R. Peralta,et al.  Catecholase and DNase activities of copper(II) complexes containing phenolate‐type ligands , 2010 .

[30]  R. Peralta,et al.  Oxygen-independent photonuclease activity of a new iron(II) complex. , 2010, Chemical communications.

[31]  A. Neves,et al.  A synthetic dinuclear copper(II) hydrolase and its potential as antitumoral: cytotoxicity, cellular uptake, and DNA cleavage. , 2009, Journal of inorganic biochemistry.

[32]  Nigel G. R. Hearns,et al.  Novel Layering of Aqua and Imidazolidinyl Phenolate Bridged Cationic [CuII2(μ-L)(μ-H2O)·H2O]2 Units Over CuINCS Based One-Dimensional Anionic Parallel Chains as Diamagnetic Coordination Framework Host , 2009 .

[33]  Peng Huang,et al.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.

[34]  A. Neves,et al.  Mononuclear Cu(II)-phenolate bioinspired complex is catalytically promiscuous: phosphodiester and peptide amide bond cleavage. , 2009, Inorganic chemistry.

[35]  Anthony L. Spek,et al.  Structure validation in chemical crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.

[36]  A. Szuławska,et al.  Cytotoxic effect, differentiation, inhibition of growth and theoretical calculations of an N,N-donor ligands and its platinum(II), palladium(II) and copper(II) complexes. , 2008, Journal of inorganic biochemistry.

[37]  D. Vourloumis,et al.  Novel copper(II) complex of N-propyl-norfloxacin and 1,10-phenanthroline with enhanced antileukemic and DNA nuclease activities. , 2008, Journal of medicinal chemistry.

[38]  Amrita Das,et al.  Rationalizing the effects of amino acid side chain, pyridine, and imidazole on the assembly and reversible disassembly of a octanuclear Cu(II) complex , 2007 .

[39]  A. J. Augustine,et al.  O2 and N2O activation by Bi-, Tri-, and tetranuclear Cu clusters in biology. , 2007, Accounts of chemical research.

[40]  C. Hong,et al.  [CuII4] clusters from the self-assembly of two imidazolidinyl 2-phenolate-bridged [CuII2] units : The role of the chloride bridge , 2007 .

[41]  M. Sosa-Torres,et al.  Comparative study of the influence of the metal centres: Fe(III), Cu(II) and Zn(II), on the ring opening and oxidative dehydrogenation reactions occurring in a coordinated imidazolidine ligand , 2005 .

[42]  W. Wong,et al.  Μ-η1:η1-N,N'-imidazolidine-bridged dicopper(II/III) complexes of a new dinucleating μ-bis(tetradentate) schiff base ligand : Synthesis, structural characterization, 1H NMR spectroscopy, and magnetic coupling , 2005 .

[43]  R. Peralta,et al.  New mononuclear CuII and ZnII complexes capable of stabilizing phenoxyl radicals as models for the active form of galactose oxidase , 2005 .

[44]  E. D. de Souza,et al.  Hydrolytic protein cleavage mediated by unusual mononuclear copper(II) complexes: X-ray structures and solution studies. , 2005, Inorganic chemistry.

[45]  A. Mangrich,et al.  Copper(II) complexes with {N,N′,N,N′-bis[(2-hydroxybenzyl) (2-pyridylmethyl)]-1,3-propanediamine}—H2bbppn: their suitability as models for the inactive form of galactose oxidase , 2003 .

[46]  W. A. Ortiz,et al.  Phosphate diester hydrolysis and DNA damage promoted by new cis-aqua/hydroxy copper(II) complexes containing tridentate imidazole-rich ligands. , 2003, Inorganic chemistry.

[47]  T. Agag,et al.  Novel benzoxazine monomers containing p-phenyl propargyl ether: Polymerization of monomers and properties of polybenzoxazines , 2001 .

[48]  Xin Liu,et al.  Effects of molecular structure parameters on ring-opening reaction of benzoxazines , 2001 .

[49]  W. Su,et al.  Comparison of in vitro growth-inhibitory activity of carboplatin and cisplatin on leukemic cells and hematopoietic progenitors: the myelosuppressive activity of carboplatin may be greater than its antileukemic effect. , 2000, Japanese Journal of Clinical Oncology.

[50]  C. L. Cheung,et al.  Structure-Reactivity Studies in Copper(II)-Catalyzed Phosphodiester Hydrolysis. , 1999, Inorganic Chemistry.

[51]  Maria Cristina Burla,et al.  SIR97: a new tool for crystal structure determination and refinement , 1999 .

[52]  W. Kaim,et al.  Copper—A “Modern” Bioelement , 1996 .

[53]  D. Wahnon,et al.  Reactivity of Copper(II) Hydroxides and Copper(II) Alkoxides for Cleaving an Activated Phosphate Diester , 1995 .

[54]  H. Adams,et al.  Heteroleptic tripodal complexes of copper(II): towards a synthetic model for the active site in galactose oxidase , 1995 .

[55]  K. Karlin,et al.  Chemistry of Pentacoordinate [LCuII-Cl]+ Complexes with Quinolyl Containing Tripodal Tetradentate Ligands L , 1994 .

[56]  A. Neves,et al.  Synthesis, crystal structure, electrochemical, and spectroelectrochemical properties of the new manganese(III) complex [MnIII(BBPEN)][PF6] [H2BBPEN = N,N'-bis(2-hydroxybenzyl)-N,N'-bis(2-methylpyridyl)ethylenediamine] , 1992 .

[57]  P. R. Norman.  Enhanced hydrolysis of neutral phosphate esters by the zinc(II) complex of 1,4,7,10-tetra-azacyclododecane , 1987 .

[58]  A. W. Addison,et al.  Synthesis, structure, and spectroscopic properties of copper(II) compounds containing nitrogen–sulphur donor ligands; the crystal and molecular structure of aqua[1,7-bis(N-methylbenzimidazol-2′-yl)-2,6-dithiaheptane]copper(II) perchlorate , 1984 .

[59]  J. Lehn,et al.  STABILITIES OF MONONUCLEAR AND DINUCLEAR MACROCYCLIC COMPLEXES OF 1,4,7,13,16,19-HEXAAZA-10,22-DIOXACYCLOTETRACOSANE (BISDIEN) , 1983 .

[60]  W. Geary.  The use of conductivity measurements in organic solvents for the characterisation of coordination compounds , 1971 .

[61]  B. Hathaway,et al.  The electronic properties and stereochemistry of mono-nuclear complexes of the copper(II) ion , 1970 .

[62]  R. J. Ferm,et al.  The Chemistry of the 2-Imidazolines and Imidazolidines. , 1954 .